# Statins to Prevent Cancer Associated Blood Clots

> **NCT07303816** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 4000 (estimated)

## Conditions studied

- Venous Thromboembolism
- Cancer
- Cardiovascular Events

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Placebo Drug

## Key facts

- **NCT ID:** NCT07303816
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2031-03-31
- **Final completion:** 2032-03-31
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07303816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07303816, "Statins to Prevent Cancer Associated Blood Clots". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07303816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*